Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Satisfaction and Treatment Experiences With RitlEcitiNib And Traditional Treatments for Severe Alopecia Areata Among Adults in the United States (SERENATA)

NCT07200128 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07200128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07200128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Satisfaction and Treatment Experiences With RitlEcitiNib And Traditional Treatments for Severe Alopecia Areata Among Adults in the United States (SERENATA)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 3, 2025
Completion date
May 30, 2025
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe alopecia areata